Article
16 Aug 2024
CN SAMR Antitrust Guidelines For The Pharmaceutical Sector (Draft For Comments)
CONTRIBUTING SINCE MAY 2018
Toby Mak
Dr. Toby Mak is somewhat unique as a registered Chinese patent attorney, as he was trained under the UK patent system, and has passed some of the UK patent attorney’s examination papers. He actively publishes articles on Chinese IP, and speaks on Chinese IP for various organizations around the world.
POPULAR TOPICS
Intellectual Property
Technology
Antitrust/Competition Law
COMPANIES CONTENT
Article
29 May 2024
China's Experimental Attempts To Monetize Patents
Article
05 Jan 2024
CNIPA's Guidelines On The Distinctiveness Of Unconventional Trademarks
Article
04 Jan 2024
Chinese Patent Examination Guidelines 2023 – Toby's Observations
Article
02 Jan 2024
Christmas Present From China – Implementation Regulations (IMR) Of The Chinese Patent Law (2023)
Article
18 Dec 2023
Two CN IP Updates – CNIPA's Continuing Cracking Down On Malicious IP Agencies, And Shanghai Free Trade Zone (SFTZ) Opening-up Overall Plan
Article
08 Dec 2023
Released On 1 Dec 2023 - Draft Provisions On Standards On Evidence For Trademark
Article
31 Oct 2023
Yet Another Two CN IP Updates
Article
31 Oct 2023
Two IP Updates From China – Draft Regulations On Patent Firms Advertising, And For PCT Application Filed With CNIPA As The RO, Using EPO As ISA
Article
13 Oct 2023
China Announced Technology Ethics Review Measures (Trial)
